Mary Cranston is a seasoned corporate director and investor. She is the retired CEO and Chair Emeritus of Pillsbury Winthrop Shaw Pittman LLP. As CEO from 1999 to 2006, she expanded PWSP internationally, doubling its size and profitability. She currently serves as a director of Visa, the Chemours Company, MyoKardia, CSAA Insurance, Aretec, Boardspan and Fiduciary Trust. She served as a Trustee of Stanford University from 2000 to 2010, and as the Chair of the Board of the Stanford Children’s Hospital until December 2016. She has also chaired the Stanford Alumni Association, the Stanford Law School Board of Visitors, and the Stanford Children’s Research Initiative. She currently sits on the boards of the Commonwealth Club of California (which she chaired from 2008 to 2010) and of Catalyst. She has been recognized by the National Law Journal as one of the 100 most influential lawyers in the United States, and by the National Association of Corporate Directors as one of the 50 most influential and effective public company directors in America. Mary has served as an advisor and investor to numerous startups in technology, financial technology and pharmaceuticals.